Ads
related to: pfizer stock price per share- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Trade
Search results
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 11 hours agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Potential Price Increase for Pfizer Inc.
Knox Daily· 1 day agoIn the deal valued at $26.47 per share,3,000 shares were bought. As a result of this transaction...shares worth roughly $0.26 million. Argus downgraded ...
Is Pfizer the Best Dividend Stock for You? | The Motley Fool
The Motley Fool· 3 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (PFE 1.63%) benefitted...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 21 hours ago(NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,166,747 shares of the biopharmaceutical ...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 7 days agoBecause of this, empirical studies indicate a strong correlation between trends in earnings estimate...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 4 days agoPerformance of an Industry Player Pfizer belongs to the Zacks Large Cap Pharmaceuticals industry....
2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips? | The Motley Fool
The Motley Fool· 7 days agoShares of Pfizer (PFE -2.01%) and Walgreens Boots Alliance (WBA -4.05%) have been beaten down more...
Obesity Drug Stocks: Where to Invest Now
Morningstar· 7 days agoThe challenge is that both stocks currently trade in overvalued territory, according to Morningstar analysts. “We think current share prices do not...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoIn the first quarter, Halozyme earned an adjusted 79 cents per share on $196 million in sales, up a...
NVIDIA is a shoo-in for the Dow post stock split By Investing.com
Investing.com· 4 days agoThe split, which will be distributed at the close on June 7th, will give shareholders ten shares in...